CD8+ and CD4+ T cells are more numerous around and in contact with PDL-1+ TAM than PD-L1- TAMs suggesting that the PD-L1+ TAMs may either promote anti-tumor immunity through antigen presentation or immunosuppression through the engagement of PD-1 (10). The gene discussed is CD4; the disease is neoplasm.